Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2026)

Maravai Lifesciences Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 15.18% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $26.0 million (down 40.47% YoY), while the FY2025 annual figure was $27.0 million, down 43.41% from the prior year.
• Interest Expenses was $5.7 million for Q1 2026 at Maravai Lifesciences Holdings, down from $6.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $15.4 million in Q4 2023 to a low of $2.7 million in Q1 2022.
• Historically, Interest Expenses has averaged $8.6 million across 5 years, with a median of $7.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Interest Expenses sank 66.3% in 2022, then surged 344.18% in 2023.
• A 5-year view of Interest Expenses shows it stood at $10.2 million in 2022, then jumped by 51.28% to $15.4 million in 2023, then fell by 26.86% to $11.3 million in 2024, then sank by 41.8% to $6.6 million in 2025, then fell by 12.3% to $5.7 million in 2026.
• The last three Interest Expenses figures came in at $5.7 million (Q1 2026), $6.6 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.